| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $14.9M | -23.9% |
| SG&A Expense | $14.5M | +0.0% |
| Operating Income | -$44.5M | -1.5% |
| Interest Expense | $11.0M | -44.8% |
| Income Tax | $0 | — |
| Net Income | -$40.7M | +33.2% |
| EPS (Basic) | -$0.94 | +64.3% |
| EPS (Diluted) | -$0.94 | +64.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $181.7M | +266.7% |
| Accounts Receivable | $609K | +65.0% |
| Inventory | $1.4M | +4.6% |
| Current Assets | $187.5M | +243.4% |
| Total Assets | $263.0M | +87.7% |
| Current Liabilities | $7.7M | +33.5% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$82.9M | -130.9% |
| Capital Expenditures | $564K | -55.0% |
| Investing Cash Flow | $4.1M | -34.8% |
| Financing Cash Flow | $205.9M | +894.4% |
| Free Cash Flow | -$83.4M | -124.6% |
| Total Liabilities |
| $49.3M |
| -71.6% |
| Stockholders' Equity | $213.7M | +739.5% |